Elevated circulating growth differentiation factor 15 is related to decreased heart rate variability in chronic

Lulu Wang1, Jing Luo1, Wenjin Liu2

  • 1Center for Kidney Disease, 2nd Affiliated Hospital, Nanjing Medical University, Nanjing, China.

Renal Failure
|February 11, 2021
PubMed

Insights

Increased Growth Differentiation Factor 15 (GDF15) in chronic kidney disease (CKD) patients is linked to reduced heart rate variability (HRV). Further research is needed to understand GDF15

Area of Science:

  • Cardiovascular Research
  • Nephrology
  • Biomarkers

Background:

  • Growth Differentiation Factor 15 (GDF15) is a transforming growth factor beta superfamily member.
  • Elevated GDF15 levels are associated with cardiovascular disease risk.
  • The specific impact of GDF15 on the cardiovascular system in chronic kidney disease (CKD) patients requires further investigation.

Purpose of the Study:

  • To analyze the detailed effect of GDF15 on the cardiovascular system in patients with CKD.
  • To investigate the association between plasma GDF15 concentrations and cardiovascular parameters in CKD patients.

Main Methods:

  • Study included 355 non-dialysis CKD patients.
  • Assessed blood pressure, endothelial function, pulse wave velocity, and heart rate variability (HRV).
  • Measured plasma GDF15 concentration using enzyme-linked immunosorbent assay.

Main Results:

  • Higher plasma GDF15 concentrations correlated with decreased estimated glomerular filtration rate (eGFR) and increased urine protein-to-creatinine ratio (uPCR).
  • Multivariable analysis revealed a negative association between plasma GDF15 and HRV parameters (SDNN, RMSSD, Triangular Index).
  • Mean GDF15 level was 1394.7 (±610.1) pg/mL in participants with a mean eGFR of 50.1 (±33.2) mL/min/1.73m².

Conclusions:

  • A significant link exists between elevated plasma GDF15 and reduced heart rate variability (HRV) in CKD patients.
  • The underlying mechanisms and predictive value of GDF15 in cardiovascular disease within the CKD population warrant further study.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
79
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
326
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
352
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
142
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
202
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
610